Signet Private Wealth LLC Makes New Investment in Marsh & McLennan Companies, Inc. $MRSH

Signet Private Wealth LLC acquired a new stake in shares of Marsh & McLennan Companies, Inc. (NYSE:MRSH) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 3,945 shares of the financial services provider’s stock, valued at approximately $732,000.

Several other large investors also recently made changes to their positions in the company. Numerai GP LLC lifted its stake in Marsh & McLennan Companies by 966.2% during the 3rd quarter. Numerai GP LLC now owns 37,220 shares of the financial services provider’s stock valued at $7,501,000 after acquiring an additional 33,729 shares in the last quarter. Swiss Life Asset Management Ltd raised its holdings in shares of Marsh & McLennan Companies by 9.5% in the fourth quarter. Swiss Life Asset Management Ltd now owns 134,542 shares of the financial services provider’s stock valued at $24,960,000 after purchasing an additional 11,648 shares during the last quarter. Barclays PLC lifted its position in shares of Marsh & McLennan Companies by 41.7% during the third quarter. Barclays PLC now owns 2,202,372 shares of the financial services provider’s stock valued at $443,844,000 after purchasing an additional 647,987 shares in the last quarter. Sarasin & Partners LLP grew its position in Marsh & McLennan Companies by 0.9% in the 4th quarter. Sarasin & Partners LLP now owns 934,732 shares of the financial services provider’s stock worth $173,411,000 after purchasing an additional 8,283 shares in the last quarter. Finally, Brown Brothers Harriman & Co. increased its stake in Marsh & McLennan Companies by 26.4% in the 3rd quarter. Brown Brothers Harriman & Co. now owns 136,179 shares of the financial services provider’s stock valued at $27,444,000 after buying an additional 28,419 shares during the last quarter. 87.99% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on MRSH. Morgan Stanley cut their target price on Marsh & McLennan Companies from $195.00 to $190.00 and set an “equal weight” rating on the stock in a research note on Monday, April 6th. Mizuho dropped their price target on Marsh & McLennan Companies from $199.00 to $193.00 and set a “neutral” rating on the stock in a report on Monday, April 13th. Piper Sandler reduced their price objective on Marsh & McLennan Companies from $190.00 to $182.00 and set a “neutral” rating for the company in a research note on Tuesday, May 26th. Keefe, Bruyette & Woods lifted their target price on Marsh & McLennan Companies from $200.00 to $203.00 and gave the stock a “market perform” rating in a research note on Friday, April 17th. Finally, Weiss Ratings downgraded shares of Marsh & McLennan Companies from a “hold (c)” rating to a “hold (c-)” rating in a report on Monday, May 11th. One investment analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, ten have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Marsh & McLennan Companies has an average rating of “Hold” and a consensus price target of $200.19.

Marsh & McLennan Companies Trading Up 1.1%

Marsh & McLennan Companies stock opened at $167.30 on Thursday. Marsh & McLennan Companies, Inc. has a 12 month low of $156.60 and a 12 month high of $220.32. The company has a market capitalization of $80.82 billion, a P/E ratio of 20.91, a PEG ratio of 2.41 and a beta of 0.62. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 1.28.

Marsh & McLennan Companies (NYSE:MRSH) last issued its earnings results on Thursday, April 16th. The financial services provider reported $3.29 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.21 by $0.08. Marsh & McLennan Companies had a return on equity of 31.87% and a net margin of 14.26%.The firm had revenue of $7.30 billion for the quarter. The business’s revenue was up 7.6% compared to the same quarter last year. Sell-side analysts expect that Marsh & McLennan Companies, Inc. will post 10.38 earnings per share for the current fiscal year.

Insider Transactions at Marsh & McLennan Companies

In other Marsh & McLennan Companies news, CEO John Q. Doyle sold 16,656 shares of the company’s stock in a transaction dated Tuesday, June 2nd. The shares were sold at an average price of $161.71, for a total transaction of $2,693,441.76. Following the sale, the chief executive officer directly owned 116,811 shares of the company’s stock, valued at $18,889,506.81. This represents a 12.48% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.38% of the company’s stock.

Marsh & McLennan Companies Company Profile

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.